-
2161por Brener, Loren, Wilson, Hannah, Jackson, L Clair, Johnson, Priscilla, Saunders, Veronica, Treloar, Carla“…Aboriginal Australians (n = 203) living with hepatitis C completed a survey assessing community attachment, stigma, resilience, quality of life, treatment intent, hepatitis C knowledge and positive lifestyle changes. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2162por Franco, Ricardo A., Overton, E. Turner, Tamhane, Ashutosh R., Forsythe, Jordan M., Rodgers, Joel B., Schexnayder, Julie K., Guthrie, Deanne, Thogaripally, Suneetha, Zinski, Anne, Saag, Michael S., Mugavero, Michael J., Wang, Henry E., Galbraith, James W.“…Emergency departments (EDs) are high-yield sites for hepatitis C virus (HCV) screening, but data regarding linkage to care (LTC) determinants are limited. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2163por Feld, Jordan J., Jacobson, Ira M., Sulkowski, Mark S., Poordad, Fred, Tatsch, Fernando, Pawlotsky, Jean‐Michel“…Over the past two decades, ribavirin has been an integral component of treatment for hepatitis C virus (HCV) infection, where it has been shown to improve the efficacy of (pegylated) interferon. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2164por Zachou, Kalliopi, Arvaniti, Pinelopi, Gatselis, Nikolaos K., Azariadis, Kalliopi, Papadamou, Georgia, Rigopoulou, Eirini, Dalekos, George N.“…BACKGROUND & OBJECTIVES: In the past, patients with haemoglobinopathies were at high risk of acquiring hepatitis C virus (HCV) due to multiple transfusions before HCV screening. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2165“…Hepatitis C virus (HCV) infection remains a significant medical concern in the United States and around the world. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2166por Xu, Zhen, Lin, Ji-Zong, Lin, Guo-Li, Wei, Fang-Fang, Liu, Jing, Zhao, Zhi-Xin, Zhang, Ying, Ke, Wei-Ming, Zhang, Xiao-Hong“…The association between serum hepatitis C virus (HCV) load and hepatic injury in HCV-infected patients has been extensively investigated. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2167“…OBJECTIVES: To determine awareness about hepatitis C among 4(th) -year medical students at Dammam University, on hepatitis C and possible associated factors. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2168por Arooj, Mahwish, Malik, Arif, Basit, Abdul, Husain Qazi, Mahmood, Asif, Muhammad, Sarwar Jamal, Mohammad, Mostafa Mahmoud, Maged, Choudhry, Hani, Natesan Pushparaj, Peter, Rasool, MahmoodEnlace del recurso
Publicado 2016
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2169por Eltahla, Auda A., Leung, Preston, Pirozyan, Mehdi R., Rodrigo, Chaturaka, Grebely, Jason, Applegate, Tanya, Maher, Lisa, Luciani, Fabio, Lloyd, Andrew R., Bull, Rowena A.“…Resistance against new hepatitis C virus (HCV) antivirals is an area of increasing interest. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2170por Ballester-Ferré, Maria Pilar, Martínez, Fernando, Garcia-Gimeno, Natalia, Mora, Francisco, Serra, Miguel A“…Chronic hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease worldwide. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2171“…Treatment of patients with chronic kidney disease (CKD) and chronic hepatitis C (CHC) differs from that used in the general CHC population mostly when glomerular filtration rate (GFR) is below 30 mL/min, as sofosbuvir, the backbone of several current regimens, is officially contraindicated. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2172“…AIM: To reduce hepatic and extrahepatic complications of chronic hepatitis C in kidney transplant recipients. METHODS: We conducted a systematic review of kidney only transplant in patients with hepatitis C and advanced fibrosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2173por Duncan, Ian, Curtis, Ric, Reyes, Juan Carlos, Abadie, Roberto, Khan, Bilal, Dombrowski, Kirk“…Due to the high cost of treatment, preventative measures to limit Hepatitis C (HCV) transmission among people who inject drugs (PWID) are encouraged by many public health officials. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2174“…Hepatitis C virus (HCV) is a global pandemic, with nearly 200 million infected patients worldwide. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2175por Chindamo, Maria Chiara, Boursier, Jerome, Luiz, Ronir Raggio, Fouchard-Hubert, Isabelle, Pannain, Vera Lúcia Nunes, de Araújo Neto, João Marcello, Coelho, Henrique Sérgio Moraes, de Mello Perez, Renata, Calès, Paul, Villela-Nogueira, Cristiane Alves“…AIM: To evaluate the performance of FibroMeter(Virus3G) combined to the first generation tests aspartate aminotransferase-to-platelet ratio index (APRI) or Forns index to assess significant fibrosis in chronic hepatitis C (CHC). METHODS: First generation tests APRI or Forns were initially applied in a derivation population from Rio de Janeiro in Brazil considering cut-offs previously reported in the literature to evaluate significant fibrosis. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2176“…AIM: To summarise the literature data on hepatitis C virus (HCV)-infected patients concerning the prevalence of glucose abnormalities and associated risk. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2177por Ivanov, Alexander V., Valuev-Elliston, Vladimir T., Tyurina, Daria A., Ivanova, Olga N., Kochetkov, Sergey N., Bartosch, Birke, Isaguliants, Maria G.Enlace del recurso
Publicado 2016
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2178por Gupta, Neil, Kabahizi, Jules, Mukabatsinda, Constance, Walker, Timothy David, Musabeyezu, Emmanuel, Kiromera, Athanase, Van Nuil, Jennifer Ilo, Steiner, Kevin, Mukherjee, Joia, Nsanzimana, Sabin, Mbituyumuremyi, Aimable“…BACKGROUND: Access to treatment for hepatitis C virus (HCV) in sub-Saharan Africa is extremely limited. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2179“…BACKGROUND: All-oral regimens are associated with higher effectiveness and shorter treatment duration for chronic hepatitis C. Given its superior effect and enormous patients in China, clinicians or patients may be compelled to consider delaying treatment for all-oral regimen. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2180por Machado, Soraia Mafra, de Almeida, Cesar, Pinho, João Renato Rebello, Malta, Fernanda de Mello, Capuani, Ligia, Campos, Aléia Faustina, Abreu, Fatima Regina Marques, Nastri, Ana Catharina de Seixas Santos, Santana, Rúbia Anita Ferraz, Sabino, Ester Cerdeira, Mendes-Correa, Maria Cássia“…OBJECTIVE: To investigate the HCV cascade of care and to identify the factors associated with loss or absence to follow-up of patients identified as infected with hepatitis C through blood donation. METHODS: Blood donors from 1994 to 2012, identified with positive anti- HCV by enzyme immunoassay and immunoblot tests were invited to participate in the study, through letters or phone calls. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto